Karen Mossman

Karen Mossman

McMaster University

H-index: 70

North America-Canada

About Karen Mossman

Karen Mossman, With an exceptional h-index of 70 and a recent h-index of 42 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Molecular Virology, Innate Immunity, Oncolytic Viruses.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunological features of bats: resistance and tolerance to emerging viruses

Fatal attractions that trigger inflammation and drive atherosclerotic disease

Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells

A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera

Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer

Differential Cellular Sensing of Fusion from within and Fusion from without during Virus Infection

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R. 1 Lineage Variants, Canada

Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1

Karen Mossman Information

University

Position

Professor of Pathology and Molecular Medicine

Citations(all)

13983

Citations(since 2020)

6987

Cited By

9513

hIndex(all)

70

hIndex(since 2020)

42

i10Index(all)

132

i10Index(since 2020)

109

Email

University Profile Page

McMaster University

Google Scholar

View Google Scholar Profile

Karen Mossman Skills & Research Interests

Molecular Virology

Innate Immunity

Oncolytic Viruses

Top articles of Karen Mossman

Title

Journal

Author(s)

Publication Date

Immunological features of bats: resistance and tolerance to emerging viruses

Wael L Demian

Olga Cormier

Karen Mossman

2024/3/1

Fatal attractions that trigger inflammation and drive atherosclerotic disease

Hitesh Sharma

Karen Mossman

Richard C Austin

2024/1/29

Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells

Journal for Immunotherapy of Cancer

Jordon M Inkol

Michael J Westerveld

Shayla G Verburg

Scott R Walsh

Jodi Morrison

...

2024

A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera

The Journal of Immunology

Patrick Budylowski

Serena LL Chau

Arinjay Banerjee

Furkan Guvenc

Reuben Samson

...

2024/4/29

Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer

2023/7/27

Differential Cellular Sensing of Fusion from within and Fusion from without during Virus Infection

Viruses

David N Hare

Tetyana Murdza

Susan Collins

Katharina Schulz

Subhendu Mukherjee

...

2023/1/21

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R. 1 Lineage Variants, Canada

Emerging Infectious Diseases

Rajesh Abraham Jacob

Ali Zhang

Hannah O Ajoge

Michael R D'Agostino

Kuganya Nirmalarajah

...

2023/7

Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1

Journal for Immunotherapy of Cancer

Huy-Dung Hoang

Aida Said

Nasana Vaidya

Victoria H Gilchrist

Kyle Malone

...

2023

Detection of Large Genomic RNA via DNAzyme‐Mediated RNA Cleavage and Rolling Circle Amplification: SARS‐CoV‐2 as a Model

Chemistry–A European Journal

Jimmy Gu

Amal Mathai

Connor Nurmi

Dawn White

Gurpreet Panesar

...

2023/5/11

Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors

Heliyon

Katherine Chan

Adrian Granda Farias

Hunsang Lee

Furkan Guvenc

Patricia Mero

...

2023/1/1

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

Cancers

Maria Eugenia Davola

Olga Cormier

Alyssa Vito

Nader El-Sayes

Susan Collins

...

2023/2/17

Method for treating viral infections using ask1 inhibitors

2023/12/7

Altered microRNA transcriptome in cultured human airway cells upon infection with SARS-CoV-2

Viruses

Idrissa Diallo

Rajesh Abraham Jacob

Elodie Vion

Robert A Kozak

Karen Mossman

...

2023/2/10

ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2

Antiviral Research

Wael L Demian

Rajesh Abraham Jacob

Olga Cormier

Aisha Nazli

Matthew Melki

...

2023/12/1

Discovery and use of long dsRNA mediated RNA interference to stimulate antiviral protection in interferon competent Mammalian cells

Frontiers in Immunology

Shawna L Semple

Sarah KW Au

Rajesh A Jacob

Karen L Mossman

Stephanie J DeWitte-Orr

2022/5/6

Human coronaviruses disassemble processing bodies

PLoS pathogens

Mariel Kleer

Rory P Mulloy

Carolyn-Ann Robinson

Danyel Evseev

Maxwell P Bui-Marinos

...

2022/8/23

A combination of chemotherapy and oncolytic virotherapy sensitizes colorectal adenocarcinoma to immune checkpoint inhibitors in a cDC1-dependent manner

International Journal of Molecular Sciences

Nader El-Sayes

Alyssa Vito

Omar Salem

Samuel Tekeste Workenhe

Yonghong Wan

...

2022/2/3

Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters

npj Vaccines

George Giorgi Babuadze

Hugues Fausther-Bovendo

Marc-Antoine Delavega

Brandon Lillie

Maedeh Naghibosadat

...

2022/4/26

Visualizing Early HCoV-229E Viral Infection Events Using Correlative 2D Light and 3D Electron Microscopy Techniques

Microscopy and Microanalysis

Alyssa Williams

Maria Davola

Karen Mossman

Kathryn Grandfield

Michael W Phaneuf

...

2022/8

Long dsRNA mediated RNA interference (dsRNAi) is antiviral in interferon competent mammalian cells

bioRxiv

SL Semple

RA Jacob

K Mossman

SJ DeWitte-Orr

2022/1/20

See List of Professors in Karen Mossman University(McMaster University)